(Q45862288)

17 December 2017

title

Remission of progressive multifocal leukoencephalopathy following highly active antiretroviral therapy in a patient with HIV infection (English)

1 reference

17 December 2017

progressive multifocal leukoencephalopathy

main subject

1 reference

Inui K

1

1 reference

17 December 2017

Miyagawa H

2

1 reference

17 December 2017

Sashihara J

3

1 reference

17 December 2017

Miyoshi H

4

1 reference

17 December 2017

Tanaka-Taya K

5

1 reference

17 December 2017

Nishigaki T

6

1 reference

17 December 2017

Teraoka S

7

1 reference

17 December 2017

Mano T

8

1 reference

17 December 2017

Ono J

9

1 reference

17 December 2017

Okada S

10

1 reference

17 December 2017

publication date

1 September 1999

1 reference

17 December 2017

published in

Brain and Development

1 reference

17 December 2017

volume

21

1 reference

17 December 2017

issue

6

1 reference

17 December 2017

page(s)

416-419

1 reference

17 December 2017

Prevalence of Antibodies in Human Sera against JC Virus, an Isolate from a Case of Progressive Multifocal Leukoencephalopathy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2899%2900038-8

7 January 2021

Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A review of the literature with a report of sixteen cases

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2899%2900038-8

7 January 2021

The natural history of progressive multifocal leukoencephalopathy in patients with AIDS. Canadian PML Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2899%2900038-8

7 January 2021

Remission of progressive multifocal leukoencephalopathy following splenectomy and antiretroviral therapy in a patient with HIV infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2899%2900038-8

7 January 2021

2.5 year remission of AIDS-associated progressive multifocal leukoencephalopathy with combined antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2899%2900038-8

7 January 2021

Detection of JC virus DNA in peripheral lymphocytes from patients with and without progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2899%2900038-8

7 January 2021

Response to cytarabine in progressive multifocal leucoencephalopathy in AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2899%2900038-8

7 January 2021

Efficacy of cytarabine in progressive multifocal leucoencephalopathy in AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2899%2900038-8

7 January 2021

Successful outcome of progressive multifocal leukoencephalopathy with cytarabine and interferon.

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2899%2900038-8

7 January 2021

Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team.

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2899%2900038-8

7 January 2021

Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2899%2900038-8

7 January 2021

Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2899%2900038-8

7 January 2021

10.1016/S0387-7604(99)00038-8

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017